Schrödinger, Inc. (SDGR)

NASDAQ: SDGR · IEX Real-Time Price · USD
27.00
+0.37 (1.39%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.

The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.

The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide.

Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Schrödinger, Inc.
Schrödinger logo
Country United States
Founded 1990
IPO Date Feb 6, 2020
Industry Health Information Services
Sector Healthcare
Employees 867
CEO Dr. Ramy Farid Ph.D.

Contact Details

Address:
1540 Broadway, 24th Floor
New York, New York 10036
United States
Phone 503-299-1150
Website schrodinger.com

Stock Details

Ticker Symbol SDGR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001490978
CUSIP Number 80810D103
ISIN Number US80810D1037
Employer ID 95-4284541
SIC Code 2834

Key Executives

Name Position
Dr. Ramy Farid Ph.D. Chief Executive Officer, President and Director
Dr. Richard A. Friesner Ph.D. Co-Founder, Scientific Advisory Chairman and Director
Dr. Geoffrey Craig Porges MBBS Executive Vice President and Chief Financial Officer
Yvonne Tran Esq. Chief Legal and People Officer
Dr. Robert Lorne Abel Ph.D. Executive Vice President, Chief Scientific Officer of Platform and Head of Modeling Research & Development
Dr. Karen Akinsanya Ph.D. President of Research and Development Therapeutics
Jenny Herman Senior Vice President of Finance and Corporate Controller
Prof. William Goddard III Co-Founder and Scientific Advisor
Kenneth Patrick Lorton Executive Vice President, Chief Technology Officer and Chief Operating Officer of Software
Shane Brauner Executive Vice President and Chief Information Officer

Latest SEC Filings

Date Type Title
Mar 4, 2024 144 Filing
Feb 29, 2024 8-K Current Report
Feb 28, 2024 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 28, 2024 10-K Annual Report
Feb 28, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024 144 Filing
Feb 12, 2024 144 Filing
Feb 12, 2024 144 Filing
Jan 23, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals